Sherif Rezk

1.1k total citations
41 papers, 753 citations indexed

About

Sherif Rezk is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Sherif Rezk has authored 41 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 12 papers in Hematology. Recurrent topics in Sherif Rezk's work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (12 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sherif Rezk is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (12 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sherif Rezk collaborates with scholars based in United States, Australia and Canada. Sherif Rezk's co-authors include Lawrence M. Weiss, Xiaohui Zhao, Russell K. Brynes, William Wu, Ashraf Khan, Althea McCourty, Antonio Saiz Ayala, Dominic V. Spagnolo, Xiaohui Zhao and Bharat N. Nathwani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The American Journal of Surgical Pathology.

In The Last Decade

Sherif Rezk

36 papers receiving 736 citations

Peers

Sherif Rezk

ONCOL

PFM

IMMUN

PHYSI

Keisuke Kawamoto Japan

Tadashi Motoori Japan

Roberta Burnelli Italy

Elizabeth Margolskee United States

Aliyah Rahemtullah United States

Virginia Lepage France

Piero Farruggia Italy

Eddie Hu United States

Suk Jin Choi South Korea

Su-Su Xie United States

Keisuke Kawamoto Japan

Sherif Rezk

245 ×0.6

ONCOL

279 ×1.0

PFM

60 ×0.4

215 ×1.6

IMMUN

46 ×0.5

PHYSI

Citations per year, relative to Sherif Rezk Sherif Rezk (= 1×) peers Keisuke Kawamoto

Countries citing papers authored by Sherif Rezk

Since Specialization

Citations

This map shows the geographic impact of Sherif Rezk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherif Rezk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherif Rezk more than expected).

Fields of papers citing papers by Sherif Rezk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherif Rezk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherif Rezk. The network helps show where Sherif Rezk may publish in the future.

Co-authorship network of co-authors of Sherif Rezk

This figure shows the co-authorship network connecting the top 25 collaborators of Sherif Rezk. A scholar is included among the top collaborators of Sherif Rezk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherif Rezk. Sherif Rezk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quintero‐Rivera, Fabiola, et al.. (2024). 67. An undiagnosed chronic myeloid leukemia (CML) with p190 BCR::ABL1 transcript, an extra Philadelphia chromosome, and IKARO. Cancer Genetics. 286-287. S21–S22.

Lee, Benjamin J., et al.. (2023). Anakinra versus etoposide‐based therapy added to high‐dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis. European Journal Of Haematology. 111(3). 477–484. 7 indexed citations

Evans, Mark G., et al.. (2022). Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates. Human Pathology. 130. 58–64. 1 indexed citations

Hussein, Khalid I., et al.. (2021). Evaluation of Serum Ischemia Modified Albumin Level in Male Patients with Androgenetic Alopecia. Benha Journal of Applied Sciences. 6(2). 57–60. 1 indexed citations

Zell, Jason A., Christine E. McLaren, Timothy R. Morgan, et al.. (2019). A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prevention Research. 13(2). 203–212. 23 indexed citations

Nael, Ali, et al.. (2019). Epstein-Barr virus incidental expression in bone marrow cells: a study of 230 consecutive bone marrow biopsy samples. Human Pathology. 88. 60–65. 2 indexed citations

Shestakova, Anna, et al.. (2019). Three Cases of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Involving Cerebrospinal Fluid (CSF). American Journal of Clinical Pathology. 152(Supplement_1). S111–S112. 1 indexed citations

Wang, Beverly, Nancy Clark, Jennifer Rodgers, et al.. (2019). Crucial role for pathology residents in laboratory self-inspection, a single Institute's experience. Practical Laboratory Medicine. 16. e00123–e00123. 1 indexed citations

Rezk, Sherif, Xiaohui Zhao, & Lawrence M. Weiss. (2018). Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update. Human Pathology. 79. 18–41. 44 indexed citations

10.

Zhang, Kuixing, et al.. (2018). Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual event. Human Pathology. 90. 106–110. 2 indexed citations

11.

Nael, Ali, Vighnesh Walavalkar, William Wu, et al.. (2016). CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient. American Journal of Clinical Pathology. 145(2). 258–265. 8 indexed citations

12.

Johnston, Abbey, et al.. (2015). Differentiating Benign From Malignant Bone Marrow B-Cell Lymphoid Aggregates: A Statistical Analysis of Distinguishing Features. Archives of Pathology & Laboratory Medicine. 139(2). 233–240. 9 indexed citations

13.

Rezk, Sherif, Bharat N. Nathwani, Xiaohui Zhao, & Lawrence M. Weiss. (2013). Follicular dendritic cells: origin, function, and different disease-associated patterns. Human Pathology. 44(6). 937–950. 38 indexed citations

14.

Brynes, Russell K., et al.. (2012). Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes. Human Pathology. 44(4). 512–520. 15 indexed citations

15.

Rezk, Sherif & Lawrence M. Weiss. (2007). Epstein-Barr virus–associated lymphoproliferative disorders. Human Pathology. 38(9). 1293–1304. 206 indexed citations

16.

Rezk, Sherif & Ashraf Khan. (2005). Role of Immunohistochemistry in the Diagnosis and Progression of Follicular Epithelium-Derived Thyroid Carcinoma. Applied immunohistochemistry & molecular morphology. 13(3). 256–264. 23 indexed citations

17.

Rezk, Sherif, et al.. (2004). Solitary Fibrous Tumor of the Auditory Canal. Archives of Pathology & Laboratory Medicine. 128(12). e169–e171. 16 indexed citations

18.

Rezk, Sherif, R K Brynes, Viera Nelson, et al.. (2004). β-Catenin Expression in Thyroid Follicular Lesions: Potential Role in Nuclear Envelope Changes in Papillary Carcinomas. Endocrine Pathology. 15(4). 329–338. 27 indexed citations

19.

Ayala, Antonio Saiz, et al.. (2002). Immunohistochemical expression of cyclin D1, E2F‐1, and Ki‐67 in benign and malignant thyroid lesions. The Journal of Pathology. 198(2). 157–162. 79 indexed citations

20.

Lai, Raymond, et al.. (2002). Immunohistochemical Expression of the Transcription Factor DP-1 and Its Heterodimeric Partner E2F-1 in Non-Hodgkin Lymphoma. Applied immunohistochemistry & molecular morphology. 10(4). 322–326. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact